The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Affiliation
Heidelberg University Hospital
Country
Germany
Current position
Dr. Pixberg currently works in gynecological oncology at the NCT and is in charge of the translational registry programs and the translational phase studies of breast cancer.
Education
Dr. Pixberg completed his medical studies at Heinrich Heine University Dusseldorf, Germany from 2010-2017 with residencies at Heidelberg University Hospital, Germany and Memorial Sloan Kettering Cancer Center, New York, USA. He has been a licensed physician since 2017 and has started his further training as a hematologist/oncologist at the National Center for Tumor Diseases.
Research area
Dr. Pixberg’s research focuses on translational oncology, in particular concerning the genomic landscape and evolution of breast cancer. A particular focus here is the establishment of interventional studies based on translational registry programs.
Conflict of interest
None